Presentation Effect of Availability of TAVR on Clinical Practice Presenter: Jochen Rein?hl December 15, 2015 REGISTER for free or LOG IN to view this content Aortic Valve Factoid Up Next Presentation Cell-Penetrating Pepducin Therapy Targeting PAR-1 in Subjects With CAD Presenter: PA. Gurbel December 16, 2015 More slides + Presentation Enrollment Volume Effect on Risk Factor Control and Outcomes in the SAMMPRIS Trial Presenter: David Chiu December 17, 2015 Presentation Transradial vs Transfemoral Access in Rescue PCI After Fibrinolytic Therapy Presenter: MB. Kadakia December 20, 2015 We Recommend
Presentation Cell-Penetrating Pepducin Therapy Targeting PAR-1 in Subjects With CAD Presenter: PA. Gurbel December 16, 2015
Presentation Enrollment Volume Effect on Risk Factor Control and Outcomes in the SAMMPRIS Trial Presenter: David Chiu December 17, 2015
Presentation Transradial vs Transfemoral Access in Rescue PCI After Fibrinolytic Therapy Presenter: MB. Kadakia December 20, 2015